CLOV (Clover Health Investments, Corp) Stock Analysis - Analyst Ratings

Clover Health Investments, Corp (CLOV) is a publicly traded Healthcare sector company. As of May 21, 2026, CLOV trades at $3.57 with a market cap of $1.79B and a P/E ratio of 0.00. CLOV moved +2.57% today. Year to date, CLOV is +38.61%; over the trailing twelve months it is -2.71%. Its 52-week range spans $1.58 to $4.87. Analyst consensus is buy with an average price target of $2.98. Rallies surfaces CLOV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate CLOV?

2 analysts cover CLOV: 0 strong buy, 1 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $2.98.

CLOV Key Metrics

Key financial metrics for CLOV
MetricValue
Price$3.57
Market Cap$1.79B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$4.87
52-Week Low$1.58
Volume5.68M
Avg Volume0
Revenue (TTM)$2.21B
Net Income$-56.94M
Gross Margin0.00%

CLOV Analyst Consensus

2 analysts cover CLOV: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.98.

Latest CLOV News

Recent CLOV Insider Trades

  • Priest Brady Patrick sold 98.04K (~$345.10K) on May 13, 2026.
  • Reynoso Jamie L. sold 5.83K (~$11.14K) on Mar 18, 2026.
  • Priest Brady Patrick sold 175.00K (~$379.75K) on Mar 4, 2026.

Common questions about CLOV

What do analysts rate CLOV?
2 analysts cover CLOV: 0 strong buy, 1 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $2.98.
Does Rallies show CLOV price targets?
Yes. Rallies tracks CLOV analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is CLOV research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CLOV. It does not provide personalized investment advice.
CLOV

CLOV